Study guide

3.2 Mid-Level Prescribing: PAs, CRNPs, CNMs, QACSC & Limited Purpose Schedule II Permits (LPSP)

Alabama MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Board of Pharmacy Governance & Pharmacist Licensure

1.1 Alabama State Board of Pharmacy: Structure, Powers, Rulemaking & the 2026 Nine-Member Board 1.2 Pharmacist Licensure Requirements: Examination, Education, Background Check & Reciprocity 1.3 Pharmacy Interns, Externs & Preceptor Requirements: 1,500 Practical Hours & Supervision Standards

2 Chapter 2: Pharmacy Support Personnel, Ratios & Professional Standards

2.1 Pharmacy Technicians: Registration, Qualifications, Scope of Duties & Tiered Ratios 2.2 License Renewal Cycles, Continuing Education (CE) & Inactive Status 2.3 Disciplinary Grounds, Sanctions, Administrative Hearings & Impaired Pharmacist Rehabilitation

3 Chapter 3: Prescribing Authority, Practitioner Scopes & Corresponding Responsibility

3.1 Prescriptive Authority by Profession: Independent vs. Limited Scopes 3.2 Mid-Level Prescribing: PAs, CRNPs, CNMs, QACSC & Limited Purpose Schedule II Permits (LPSP) 3.3 Corresponding Responsibility, Legitimate Medical Purpose & Red Flags for Controlled Substance Diversion

4 Chapter 4: Opioids, Controlled Substance Clinical Safeguards & Naloxone Access

4.1 Opioid Prescribing Standards: ALBME Risk & Abuse Mitigation, MME Thresholds & Pain-Management Registration 4.2 Overdose Prevention: Statewide Naloxone Standing Order, Co-Prescribing & Pharmacist Dispensing Protocols 4.3 Alabama Prescription Drug Monitoring Program (PDMP): Dispenser Daily Reporting & Prescriber Query Mandates

5 Chapter 5: Clinical Services, Immunizations & Collaborative Practice

5.1 Pharmacist Immunization Authority, Protocols & Training Standards 5.2 Collaborative Drug Therapy Management (CDTM) & Collaborative Practice Agreements 5.3 Patient Counseling & Prospective Drug Utilization Review (DUR) Standards

6 Chapter 6: Prescription Validity, Electronic Prescribing & Security Standards

6.1 Prescription Form Validity: Written, Oral/Telephone & Facsimile Requirements 6.2 Electronic Prescribing & Electronic Prescriptions for Controlled Substances (EPCS) 6.3 Alabama Generic Drug Substitution: Two-Signature Line Law & Therapeutic Equivalence

7 Chapter 7: Prescription Processing, Labeling, Packaging & Emergency Dispensing

7.1 Prescription Labeling Standards & Expiration / Beyond-Use Dating 7.2 Federal Packaging Mandates: Poison Prevention Packaging Act (PPPA) & Child-Resistant Containers 7.3 Emergency Prescription Dispensing: 72-Hour Supply Rule & Disaster Provisions 7.4 Partial Filling of Prescriptions: Non-Controlled, Schedule II & Schedules III–V

8 Chapter 8: Prescription Transfers, Delivery & Remote Pharmacy Services

8.1 Prescription Transfer Rules: Non-Controlled vs. Controlled Substances 8.2 Prescription Delivery, Mail-Order Distribution & Out-of-State Permits 8.3 Patient Records, Confidentiality & Permitted Health Information Disclosures 8.4 Remote Pharmacist Work, Off-Site Order Entry & Off-Site Vaccine Order Processing

9 Chapter 9: Pharmacy Facility Standards, Security & Operational Supervision

9.1 Pharmacy Facility Permits: Application, Inspection, Renewal & Change of Ownership 9.2 Prescription Department Technical Equipment, References & Storage Standards 9.3 Pharmacy Security, Keys & Controlled Access Standards 9.4 Supervising Pharmacist Responsibilities & Temporary Absence

10 Chapter 10: Controlled Substances: Scheduling, Ordering, Inventory & Recordkeeping

10.1 Controlled Substance Scheduling: Federal Framework & Alabama State Variations 10.2 Controlled Substance Ordering & Procurement: DEA Form 222, CSOS & Invoicing 10.3 Controlled Substance Inventory Standards: Alabama Annual Inventory on January 15 10.4 Controlled Substance Records, 2-Year Retention & Filing Systems 10.5 Drug Distribution & Supply-Chain Security: DSCSA, Wholesale Distribution & Alabama Permits

11 Chapter 11: Controlled Substance Diversion Control, Disposal & Precursor Regulation

11.1 Theft and Loss of Controlled Substances: DEA Form 106 & Alabama Board Reporting Requirements 11.2 Controlled Substance Disposal, Destruction & Reverse Distribution 11.3 Ephedrine and Pseudoephedrine Sales Restrictions: Federal & Alabama Law 11.4 Non-Prescription Products: OTC Labeling, Repackaging, Exempt Narcotics & Restricted Distribution

12 Chapter 12: Compounding Standards, Institutional Practice & Medication Safety

12.1 Non-Sterile Compounding Standards: USP <795>, Beyond-Use Dating & Alabama Standards 12.2 Sterile Compounding & Hazardous Drug Handling: USP <797>, USP <800> & Facility Requirements 12.3 Institutional Pharmacy Practice: Absence of Pharmacist, Night Cabinets, Stat Cabinets & Emergency Kits 12.4 Medication Safety, Drug Recalls (Classes I-III), Adulteration, Misbranding & Return/Reuse Prohibitions

3.2 Mid-Level Prescribing: PAs, CRNPs, CNMs, QACSC & Limited Purpose Schedule II Permits (LPSP)

Key Takeaways Explain This Topic AI

Certified Registered Nurse Practitioners (CRNPs) and Certified Nurse Midwives (CNMs) practice pursuant to a collaborative practice agreement with a collaborating physician, whereas Physician Assistants (PAs) practice under a supervising physician.

Prescribing non-controlled legend drugs is authorized exclusively through written formulary protocols approved by the respective professional boards and within the clinical specialties of both the mid-level practitioner and the physician.

A Qualified Alabama Controlled Substances Certificate (QACSC) requires 12 months of active Alabama clinical practice and 12 approved CME hours, authorizing prescribing of Schedules III through V; a QACSC alone confers zero Schedule II authority.

Under a Limited Purpose Schedule II Permit (LPSP), initial doses and any subsequent dose titrations of long-acting Schedule II medications must be initiated by the physician; mid-levels are strictly limited to maintenance continuation orders.

Controlled substance prescriptions written by mid-level practitioners must display both the mid-level's credentials (name, DEA, QACSC/LPSP number) and the collaborating or supervising physician's name, address, and telephone number; mid-levels are strictly barred from dispensing medications.

Last updated: September 2026

3.2 Mid-Level Prescribing: PAs, CRNPs, CNMs, QACSC & Limited Purpose Schedule II Permits (LPSP)

Important

Core Exam Concept : In Alabama, mid-level practitioners do not possess independent prescriptive authority. Their ability to prescribe legend drugs and controlled substances is strictly derivative, governed by collaborative agreements or supervisory protocols with licensed physicians. Controlled substance prescribing requires specialized state certification: the Qualified Alabama Controlled Substances Certificate (QACSC) for Schedules III through V, and the Limited Purpose Schedule II Permit (LPSP) for specific Schedule II agents. Alabama pharmacists must master the precise statutory limitations governing these permits, particularly the clinical boundaries between short-acting and long-acting Schedule II medications.

Mid-level practitioners represent an expanding portion of the primary care and specialty healthcare workforce in Alabama. For pharmacy candidates preparing for the Alabama MPJE, questions regarding mid-level prescriptive scope, permit prerequisites, and mandatory prescription markings appear with high frequency.

Collaborative Practice and Supervisory Frameworks

Mid-level practitioners in Alabama operate under two distinct regulatory and supervisory legal frameworks: +-----------------------------------------------------------------------------------------+

  • | Mid-Level Regulatory Structure in Alabama |
  • +-----------------------------------------------------------------------------------------+
  • | Advanced Practice Registered Nurses (CRNP & CNM) |
  • | • Legal Structure: Collaborative Practice Agreement with a Collaborating Physician |
  • | • Regulatory Bodies: Joint Committee / Alabama Board of Nursing & ALBME |
  • | |
  • | Physician Assistants (PA) |
  • | • Legal Structure: Supervisory Protocol with a Supervising Physician |
  • | • Regulatory Bodies: Alabama Board of Medical Examiners & Committee on PAs |
  • +-----------------------------------------------------------------------------------------+
  • Certified Registered Nurse Practitioners (CRNPs) and Certified Nurse Midwives (CNMs)

Governing Law : Ala. Code § 34-21-80 et seq.; Ala. Admin. Code r. 540-X-8 and r. 610-X-5.

Collaborative Practice Agreement : CRNPs and CNMs do not practice independently. They must enter into a formal, written collaborative practice agreement with a qualified, fully licensed Alabama physician ( collaborating physician ).

Scope Alignment : The collaborative practice agreement establishes the mid-level practitioner's clinical duties, approved medical protocols, and formulary. The clinical scope of the CRNP or CNM can never exceed the specialty training or scope of practice of the collaborating physician. For example, a collaborating physician who is a dermatologist cannot authorize a CRNP to run an obstetrical or cardiology clinic under their collaborative agreement.

Physician Assistants (PAs)

Governing Law : Ala. Code § 34-24-290 et seq.; Ala. Admin. Code r. 540-X-7.

Supervisory Protocol : PAs practice under the direction and supervision of an approved supervising physician . The PA is considered an agent of the supervising physician.

Supervisory Guidelines : The supervising physician is responsible for overseeing the PA's clinical activities, conducting regular chart audits, ensuring emergency coverage, and defining the specific clinical tasks and formulary delegated to the PA.

Non-Controlled Prescriptive Authority

Under their respective collaborative agreements and supervisory protocols:

Mid-level practitioners may be granted authority to prescribe non-controlled legend drugs.

Formulary Protocol : Prescribing is limited to drugs listed in the approved collaborative practice formulary. Formulary exclusions typically include general anesthetics, chemotherapeutic regimens, and abortifacient drugs, unless explicitly approved by the joint committee under specialty protocols.

Valid Prescription Orders : A prescription for a non-controlled legend drug issued by a CRNP, CNM, or PA within their approved formulary is legally valid and may include whatever refills the prescriber authorizes; Alabama places no statutory expiration on a non-controlled legend prescription, so the prescriber's authorization and the pharmacist's professional judgment set the practical limit.

Qualified Alabama Controlled Substances Certificate (QACSC)

A basic nursing or physician assistant license confers zero authority to prescribe controlled substances . In Alabama, controlled substance prescribing for mid-levels is regulated under the Alabama Uniform Controlled Substances Act (Ala. Code § 20-2-250 et seq.) through the issuance of a Qualified Alabama Controlled Substances Certificate (QACSC) .

Mandatory Eligibility Criteria

To apply for and receive an initial QACSC from the Alabama Board of Medical Examiners, a mid-level practitioner must satisfy all four of the following prerequisites:

Active License : Hold a current, active, unrestricted license as a Registered Nurse and approval as a CRNP or CNM in Alabama, or an active license as a PA in Alabama.

Clinical Practice Experience : Have engaged in active clinical practice in Alabama for a minimum of twelve (12) continuous months under an approved collaborative practice agreement or supervisory arrangement.

Controlled Substance CME Requirement : Complete a minimum of twelve (12) approved Continuing Medical Education (CME) contact hours within the preceding 24 months. The curriculum must include advanced pharmacology and approved prescribing guidelines for controlled substances (specifically covering pain management, substance use disorder identification, and Alabama prescribing statutes).

Federal DEA Registration : Obtain an active federal DEA mid-level registration (prefixed with the letter "M") following initial state certificate approval.

Prescriptive Scope of the QACSC

Permitted Schedules : A mid-level practitioner holding a valid QACSC is authorized to prescribe, administer, and order controlled substances listed in Schedules III, IV, and V .

Schedule II Prohibition : A standard QACSC conveys absolutely NO authority to prescribe Schedule II controlled substances. Prescribing any Schedule II drug (e.g., oxycodone, hydrocodone/APAP, methylphenidate, amphetamine salts) under a standard QACSC is an illegal act subject to felony prosecution.

Protocol Bounds : Even within Schedules III–V, the mid-level may only prescribe medications authorized in their specific written collaborative formulary.

Limited Purpose Schedule II Permit (LPSP)

Recognizing that certain clinical practices (such as oncology, hospice, and long-term care) require mid-level access to Schedule II medications, the Alabama Legislature enacted Act 2013-223 (codified at Ala. Code § 20-2-260 et seq.), establishing the Limited Purpose Schedule II Permit (LPSP) .

Statutory Prerequisites for LPSP

A CRNP, CNM, or PA seeking Schedule II authority must satisfy rigorous qualification standards:

Active QACSC : Must hold an active, unrestricted QACSC in good standing.

Practice Experience & Endorsement : Must have operated under an approved collaborative or supervisory practice with specific Schedule II exposure, supported by the formal recommendation of the collaborating/supervising physician.

Specialized Schedule II Education : Must complete an approved course of at least four (4) contact hours of Category 1 CME specifically addressing Schedule II controlled substances prescribing and monitoring.

Board-Approved Formulary : Must submit a practice-specific Schedule II formulary application approved jointly by the Alabama Board of Medical Examiners and Board of Nursing / PA Committee.

Critical Prescriptive Guardrails: Long-Acting vs. Short-Acting Schedule IIs

Alabama law enforces a vital clinical distinction between short-acting and long-acting Schedule II medications:

Schedule II Drug Category Definition & Examples Initiation Authority Titration / Dose Increase Authority Maintenance Refill Authority

Short-Acting Schedule II Drugs Immediate-release formulations (e.g., hydrocodone/APAP, oxycodone IR, methylphenidate IR, dextroamphetamine) Mid-Level Permitted (if included on approved LPSP formulary) Mid-Level Permitted (within protocol limits) Mid-Level Permitted (maximum 30-day supply, no refills under C-II law)

Long-Acting Schedule II Drugs Extended-release or continuous-delivery formulations (e.g., OxyContin, MS Contin, fentanyl transdermal patches, methadone, extended-release hydrocodone) PHYSICIAN ONLY (Must be initiated directly by collaborating/supervising physician) PHYSICIAN ONLY (Any increase in strength or frequency must be ordered by physician) Mid-Level Permitted (Maintenance continuation orders only; max 30-day supply)

Warning

The Long-Acting Initiation Trap : An MPJE question may describe a hospice or chronic pain patient being seen by an experienced CRNP with an LPSP. The CRNP decides to switch the patient from short-acting hydrocodone to a long-acting fentanyl transdermal patch or OxyContin, and writes the initial prescription. Under Alabama law, this prescription is ILLEGAL. The CRNP cannot initiate or titrate long-acting Schedule II medications. The collaborating physician must personally evaluate the patient and write the initial order. Only after the physician establishes the dosage can the CRNP write subsequent maintenance orders.

Approved Indications and Settings for LPSP

Schedule II authority is not granted across the board. It is restricted to specific approved specialty fields or clinical settings, including:

Inpatient and outpatient oncology and hematology practices.

Palliative care and certified hospice organizations.

Licensed nursing home facilities and long-term care institutions.

Specific surgical and medical specialty practices approved by the ALBME.

Prescription Blank Requirements for Mid-Level Practitioners

When an Alabama pharmacist evaluates a controlled substance prescription written by a mid-level practitioner, the document must contain specific statutory elements to be facially valid under Alabama Administrative Code Rules:

Mid-Level Information :

Full legal name, professional title (CRNP, CNM, or PA), practice clinic address, and telephone number.

Mid-level practitioner's federal DEA registration number (beginning with 'M').

Mid-level practitioner's QACSC number (and LPSP number if prescribing a Schedule II medication).

Collaborating / Supervising Physician Information :

Full name of the collaborating or supervising physician.

Address and telephone number of the physician's practice.

Patient and Prescription Details :

Full patient name and residential address.

Drug name, strength, dosage form, quantity, directions for use, and date issued.

Original physical or verified electronic signature of the mid-level practitioner. +-----------------------------------------------------------------------------------------+

  • | Sample Anatomy: Valid Alabama Mid-Level C-II/C-III Rx |
  • +-----------------------------------------------------------------------------------------+
  • | VALLEY HEALTH CLINIC |
  • | Jane Doe, CRNP, MSN Collaborating Physician: |
  • | QACSC #: Q-12345 LPSP #: L-0987 Dr. Robert Smith, MD |
  • | DEA #: MD1234567 100 Medical Center Way, Suite 400 |
  • | 100 Medical Center Way, Suite 400 Birmingham, AL 35242 |
  • | Birmingham, AL 35242 (205) 555-0199 (205) 555-0100 |
  • | |
  • | Date: 09/06/2026 Patient: Sarah Jenkins, DOB: 04/12/1978 |
  • | Rx: Oxycodone/APAP 5/325 mg tablet |
  • | Sig: 1 tab PO Q6H PRN severe pain |
  • | Dispense: #28 (twenty-eight) tabs |
  • | Refills: 0 |
  • | Jane Doe, CRNP |
  • | ------------------------------------------- |
  • | Signature of Mid-Level Prescriber |
  • +-----------------------------------------------------------------------------------------+

Caution

Facial Invalidation : If a mid-level practitioner writes a prescription for a controlled substance and fails to include the collaborating or supervising physician's name and contact information, the prescription is facially defective . An Alabama pharmacist cannot lawfully fill the prescription until the required physician information is obtained, verified, and recorded.

Absolute Statutory Bar on Mid-Level Dispensing

Under Alabama law (Ala. Code § 20-2-254 and Board of Pharmacy rules), prescriptive authority does NOT confer dispensing authority .

Neither a QACSC nor an LPSP authorizes a CRNP, CNM, or PA to dispense medications to a patient for a fee.

Mid-levels may distribute prepackaged manufacturer drug samples only if explicitly authorized in their approved collaborative formulary protocol.

Dispensing prescription stock, repacking bulk medications, or operating an in-clinic pharmacy dispensary is strictly restricted to licensed physicians and licensed pharmacies.